JPRN-UMIN000012901已完成2 期
Carboplatin and nab-Paclitaxel as first-line treatment in patients with advanced non-small cell lung cancer with interstitial lung disease (HOT1302) - Carboplatin and nab-Paclitaxel as first-line treatment in patients with advanced non-small cell lung cancer with interstitial lung disease (HOT1302)
Hokkaido Lung Cancer Clinical Study Group0 个研究点目标入组 36 人开始时间: 2014年1月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of Severe drug allergies 2) CVD-IP or other ILD (e.g. pneumoconiosis) with clear cause 3) Active infection 4) Oral steroid or immunosuppressant drug 5) Severe concurrent disease 6) Postive HBs antigen or positive HBs antibody with detectable HBV-DNA 7) Pleural and peritoneal effusion likely to require surgical intervention, or pericardial effusion 8) Symptomatic brain metastasis 9) Active double cancer 10) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 11) Previous treatment with nab-paclitaxel 12) Physician concludes that the patient's participation in this trial is inappropriate
研究者
相似试验
尚未招募
2 期
Carboplatin with nab-paclitaxel as first-line therapy in patients with advanced non-small-cell lung cancer and idiopathic interstitial pneumoniasnon-small-cell lung cancer with idiopathic interstitial pneumoniasJPRN-UMIN000026706Kurashiki Central Hospital Department of Respiratory medicine32
招募中
2 期
CCH2109ntreated advanced or recurrent thymic carcinomasthymic carcinomaJPRN-jRCT2031230114Okuma Yusuke35
已完成
1 期
Phase I/II trial of nab-Paclitaxel,Carboplatin,plus Bevacizumab chemotherapy for patients with advanced Non-Squamous Non-Small Cell Lung Cancer.Advanced Non-Squamous Non-Small Cell Lung CancerJPRN-UMIN000013201Cancer Institute Hospital of JFCR61
招募中
1 期
Phase I/II study of carboplatin and nab-paclitaxel and concurrent thoracic radiation for patients with Locally advanced NSCLCJPRN-UMIN000020359Gunma University50
已完成
1 期
A Phase I Study of Carboplatin and nab-Paclitaxel plus concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancernon small cell lung cancerJPRN-UMIN000013223Kochi University12